National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

PAPERBACK
price:$45.00
add to cart

Rights & Permissions

topleft topright

Evidence-Based Medicine and the Changing Nature of Health Care: Meeting Summary (IOM Roundtable on Evidence-Based Medicine) (2008)

Citation Manager

McClellan, Mark B., McGinnis, J. Michael, Nabel, Elizabeth G., Olsen, LeighAnne M.. "Appendix A: Meeting Agenda." Evidence-Based Medicine and the Changing Nature of Health Care: Meeting Summary (IOM Roundtable on Evidence-Based Medicine). Washington, DC: The National Academies Press, 2008.

Please select a format:

BibTeX EndNote RefMan


Page
173
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Evidence-Based Medicine and the Changing Nature of Health Care

Appendix A
Meeting Agenda

EVIDENCE-BASED MEDICINE AND THE CHANGING NATURE OF HEALTH CARE


THE NATIONAL ACADEMY OF SCIENCES BUILDING

2100 C STREET, N.W.

WASHINGTON, D.C.


MONDAY, OCTOBER 8

9:20 a.m.

INTRODUCTION OF THE PROGRAM

Mark B. McClellan, M.D., Ph.D., Senior Fellow and Director, Engelberg Center for Health Care Reform, Leonard D. Schaeffer Chair in Health Policy Studies, Economic Studies, The Brookings Institution

Elizabeth G. Nabel, M.D., Director, National Heart, Lung, and Blood Institute, National Institutes of Health

9:30 a.m.

WHAT FORCES ARE DRIVING THE NEED FOR BETTER MEDICAL EVIDENCE?

Chair: Denis A. Cortese, M.D., President and Chief

Executive Officer, Mayo Clinic

 

Relationship Between Health Care and the Evidence Base: Current Profile

Elliott S. Fisher, M.D., M.P.H., Professor of Medicine and Community and Family Medicine, Center for the Evaluative Clinical Sciences, Dartmouth Medical School

 

How the Pace of New Health Product Introduction Affects the Need for Evidence

Molly J. Coye, M.D., M.P.H., Founder and Chief Executive Officer, Health Technology Center

Page
173

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 173
Evidence-Based Medicine and the Changing Nature of Health Care Appendix A Meeting Agenda EVIDENCE-BASED MEDICINE AND THE CHANGING NATURE OF HEALTH CARE THE NATIONAL ACADEMY OF SCIENCES BUILDING 2100 C STREET, N.W. WASHINGTON, D.C. MONDAY, OCTOBER 8 9:20 a.m. INTRODUCTION OF THE PROGRAM Mark B. McClellan, M.D., Ph.D., Senior Fellow and Director, Engelberg Center for Health Care Reform, Leonard D. Schaeffer Chair in Health Policy Studies, Economic Studies, The Brookings Institution Elizabeth G. Nabel, M.D., Director, National Heart, Lung, and Blood Institute, National Institutes of Health 9:30 a.m. WHAT FORCES ARE DRIVING THE NEED FOR BETTER MEDICAL EVIDENCE? Chair: Denis A. Cortese, M.D., President and Chief Executive Officer, Mayo Clinic   Relationship Between Health Care and the Evidence Base: Current Profile Elliott S. Fisher, M.D., M.P.H., Professor of Medicine and Community and Family Medicine, Center for the Evaluative Clinical Sciences, Dartmouth Medical School   How the Pace of New Health Product Introduction Affects the Need for Evidence Molly J. Coye, M.D., M.P.H., Founder and Chief Executive Officer, Health Technology Center

OCR for page 174
Evidence-Based Medicine and the Changing Nature of Health Care   How the Pace of New Insights into Genetic Variation Affects the Need for Evidence David M. Altshuler, Ph.D., M.D., Director of Medical and Population Genetics, Broad Institute   Impact of the Evidence Shortfall on Health Care Costs, Public Budgets, and the Economy Peter R. Orszag, Ph.D., Director, Congressional Budget Office 10:30 a.m. QUESTIONS AND DISCUSSION 10:50 a.m. BREAK 11:10 a.m. HOW CAN PATIENTS AND PROVIDERS CONTEND WITH THE CHANGES? Chair: Michael M. E. Johns, M.D., Chancellor, Emory University   Practical Front-Line Challenges and the Future of Expert-Based Care William W. Stead, M.D., McKesson Foundation Professor of Medicine and Biomedical Informatics, and Associate Vice Chancellor for Strategy and Transformation, Vanderbilt University   The Patient-Physician Partnership in Fostering an Evidence-Driven Environment Marc Boutin, Esq., Executive Vice President, National Health Council   Information Technology Tools That Support Best Practices by Healthcare Providers Robert Hayward, M.D., M.P.H., F.R.C.P.C., Associate Professor, Departments of Medicine and Public Health Sciences, and Director, Centre for Health Evidence, University of Alberta   Consumer-Accessible, Web-Based Health Information to Empower Patients Peter M. Neupert, M.B.A., Corporate Vice President, Health Solutions Group, Microsoft Corporation 12:10 p.m. QUESTIONS AND DISCUSSION 12:30 p.m. LUNCH BREAK

OCR for page 175
Evidence-Based Medicine and the Changing Nature of Health Care 2:00 p.m. WHAT’S NEEDED TO TRANSFORM THE SPEED AND RELIABILITY OF NEW EVIDENCE? Chair: John W. Rowe, M.D., Professor, Department of Health Policy and Management, Columbia University Mailman School of Public Health   Electronic Health Records and the Prospect of Real-Time Evidence Development George C. Halvorson, Chairman and Chief Executive Officer, Kaiser Foundation Health Plan, Inc., and Kaiser Foundation Hospitals   Research Methods to Speed the Development of Better Evidence Eric D. Peterson, M.D., M.P.H., Professor of Medicine, Duke Clinical Research Institute   Biopharmaceutical and Medical Device Development: Tailored Therapies Meet Evidence-Based Medicine Steven M. Paul, M.D., Executive Vice President, Science and Technology, and President, Lilly Research Laboratories, Eli Lilly and Company 2:45 p.m. QUESTIONS AND DISCUSSION 3:00 p.m. HOW CAN POLICY CHANGES IMPROVE THE VALUE WE GET FROM HEALTH CARE? Chair: John K. Iglehart, Founding Editor, Health Affairs, and National Correspondent, New England Journal of Medicine   What Is Value in Health Care? Michael E. Porter, Ph.D., Bishop William Lawrence University Professor, Harvard Business School   Regulatory and Financing Reforms Necessary for Effective Health Care Donna E. Shalala, Ph.D., President, University of Miami 3:30 p.m. QUESTIONS AND DISCUSSION 4:00 p.m. CLOSING REMARKS Mark B. McClellan, M.D., Ph.D. Elizabeth G. Nabel, M.D.

OCR for page 176
Evidence-Based Medicine and the Changing Nature of Health Care This page intentionally left blank.